Loading clinical trials...
Loading clinical trials...
Temperature Controlled Laminar Airflow (TLA) Treatment of Moderate to Severe Atopic Eczema in Children and Adolescents - a Randomized Placebo Controlled Phase 2 Study
Conditions
Interventions
Nocturnal Temperature controlled Laminar Airflow (TLA) Treatment
Placebo TLA Device
Locations
1
United Kingdom
IMPERIAL COLLEGE HEALTHCARE NHS Trust
London, United Kingdom
Start Date
July 8, 2019
Primary Completion Date
December 31, 2024
Completion Date
May 31, 2025
Last Updated
January 8, 2024
NCT06004986
NCT06850311
NCT06454942
NCT05704205
NCT06469385
NCT04773587
Lead Sponsor
Imperial College London
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions